Acknowledgments
The authors thank all who took part in the study, as well as the families and caregivers.
This is an abstract of the Plain Language Summary of Publication article.
View the full Plain Language Summary PDF of this article to read the full-text
Link to original article here
Disclosure statement
Enrique M Ocio received honoraria from Amgen, AstraZeneca, Bristol Myers Squibb/Celgene, GlaxoSmithKline, Janssen, Oncopeptides, Pfizer, Regeneron, Sanofi, and Takeda; disclosed consulting/advisory role for AbbVie, Amgen, Bristol Myers Squibb/Celgene, GlaxoSmithKline, Janssen, Menarini/Stemline Therapeutics, Oncopeptides, Pfizer, Sanofi, and Takeda, and participation in speakers’ bureau for Janssen; received travel/accommodation expenses from Bristol Myers Squibb, GlaxoSmithKline, Janssen, and Lilly. Aurore Perrot received honoraria from AbbVie, Amgen, BMS/Celgene, GSK, Janssen, Pfizer, Sanofi, and Takeda; research funding from Takeda; and support for attending meetings and/or travel from Amgen, Janssen. Philippe Moreau disclosed honoraria and consulting/advisory role for AbbVie, Amgen, Celgene, Janssen, Oncopeptides, Roche, and Sanofi. Maria-Victoria Mateos received honoraria from AbbVie, Adaptive, Amgen, Bluebird bio, Celgene, GSK, Janssen, Oncopeptides, Pfizer, Regeneron, Roche, Sanofi, Sea-Gen, and Takeda. Sara Bringhen received honoraria from Amgen, BMS/Celgene, and Janssen, and consulting fees from BMS/Celgene, Janssen, and Takeda; disclosed participation on a data safety monitoring board or advisory board for Amgen, Celgene, GSK, Janssen, Karyopharm, and Sanofi. Joaquín Martínez-López received honoraria and consulting fees from BMS/Celgene, Incyte, Janssen, Novartis, Roche, and Sanofi; travel and accommodation support from BMS, Janssen, Novartis, Roche, and Sanofi. Lionel Karlin received honoraria from AbbVie, Amgen, Celgene, Janssen, Sanofi, and Takeda; disclosed advisory role for Amgen, Celgene, GSK, Janssen, and Takeda. Corina Oprea, Yi Li, and Ercem Kodas are employed by Sanofi and may hold stock and/or stock options in the company. Jesus San-Miguel received honoraria and consulting fees from Amgen, BMS/Celgene, GSK, Janssen, Karyopharma, Sanofi, and Takeda. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed. Medical writing support was provided by S. Mariani, MD, PhD of Envision Pharma Group, funded by Sanofi.
Patient reviewers on this PLSP have received honorarium from Future Oncology for their review work but have no other relevant financial relationships to disclose.
Peer reviewers on this manuscript have no relevant financial or other relationships to disclose.
Funding
This manuscript was funded by Sanofi.
With the authors’ consent, the funder was given the opportunity to review the manuscript for factual accuracy. Changes were made by the authors at their discretion and based on scientific or editorial merit only. The authors maintained full control over the manuscript, including content, wording, and conclusions.